China Pharma Holdings (CPHI) Work In Process (2017 - 2024)
Historic Work In Process for China Pharma Holdings (CPHI) over the last 8 years, with Q3 2024 value amounting to $334430.0.
- China Pharma Holdings' Work In Process fell 5059.28% to $334430.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $334430.0, marking a year-over-year decrease of 5059.28%. This contributed to the annual value of $413597.0 for FY2023, which is 2576.51% down from last year.
- Per China Pharma Holdings' latest filing, its Work In Process stood at $334430.0 for Q3 2024, which was down 5059.28% from $87308.0 recorded in Q2 2024.
- In the past 5 years, China Pharma Holdings' Work In Process ranged from a high of $676885.0 in Q3 2023 and a low of $87308.0 during Q2 2024
- Its 5-year average for Work In Process is $431457.2, with a median of $423493.0 in 2020.
- Per our database at Business Quant, China Pharma Holdings' Work In Process soared by 11099.1% in 2020 and then crashed by 7607.43% in 2024.
- China Pharma Holdings' Work In Process (Quarter) stood at $662999.0 in 2020, then fell by 15.97% to $557146.0 in 2021, then changed by 0.0% to $557146.0 in 2022, then fell by 25.77% to $413597.0 in 2023, then decreased by 19.14% to $334430.0 in 2024.
- Its last three reported values are $334430.0 in Q3 2024, $87308.0 for Q2 2024, and $242726.0 during Q1 2024.